首页 > 最新文献

Journal of acute medicine最新文献

英文 中文
The White Cerebellum Sign. 白色小脑标志
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2024-03-01 DOI: 10.6705/j.jacme.202403_14(1).0007
Yu-Nong Lai, Jui-Yuan Chung
{"title":"The White Cerebellum Sign.","authors":"Yu-Nong Lai, Jui-Yuan Chung","doi":"10.6705/j.jacme.202403_14(1).0007","DOIUrl":"10.6705/j.jacme.202403_14(1).0007","url":null,"abstract":"","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"48-49"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933587/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined Use of Alkaline Agents With Low-Flow Extracorporeal Carbon Dioxide Removal in Carbon Dioxide Inhalation Models Preserving Inspiratory Efforts. 在二氧化碳吸入模型中结合使用碱性制剂和低流量体外二氧化碳清除技术,以保持吸气努力。
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2024-03-01 DOI: 10.6705/j.jacme.202403_14(1).0004
Tomonori Yamashita, Akinori Uchiyama, Yusuke Enokidani, Takeshi Yoshida, Yuji Fujino

Background: Low-flow extracorporeal CO 2 removal (ECCO 2 R), managed using a renal replacement platform, is useful in achieving lung-protective ventilation with low tidal volume. However, its capacity for CO 2 elimination is limited. Whether this system is valuable in reducing strong inspiratory efforts in respiratory failure is unclear. The combined use of alkaline agents with low-flow ECCO 2 R might be useful in hypercapnic subjects preserving inspiratory efforts.

Methods: This study examined the effects of low-flow ECCO 2 R on respiratory status and investigated the effects of NaHCO 3 , trometamol, and saline on respiratory status during low-flow ECCO 2 R in CO 2 inhalation models.

Results: Although low-flow ECCO 2 R did not significantly change the respiratory rate (92.2% ± 24.3% [mean ± standard deviation] of that before ECCO 2 R), it reduced minute ventilation (MV) (78.9% ± 13.5% of that before ECCO 2 R). The addition of NaHCO 3 improved acidemia but did not change MV compared with that of the saline group (0.451 ± 0.026 L/min/kg body weight [BW] vs. 0.556 ± 0.138 L/min/kg BW, respectively). The addition of trometamol improved acidemia and reduced MV compared with that of the saline group (0.381 ± 0.050 L/min/kg BW vs. 0.556 ± 0.138 L/min/kg BW, respectively). The total amounts of CO 2 removed during ECCO 2 R in the NaHCO 3 group were lower than those in the saline and trometamol groups.

Conclusion: The low-flow ECCO 2 R reduced MV in subjects preserving spontaneous breathing efforts with CO 2 overload. The addition of NaHCO 3 improved acidemia but did not change MV, whereas the addition of trometamol improved acidemia and reduced MV.

背景:使用肾脏替代平台管理的低流量体外二氧化碳排出器(ECCO 2 R)有助于以低潮气量实现肺保护性通气。然而,它排除二氧化碳的能力有限。目前还不清楚该系统在减少呼吸衰竭患者强烈吸气方面是否有价值。将碱性制剂与低流量 ECCO 2 R 结合使用可能对高碳酸血症患者的吸气努力有所帮助:本研究探讨了低流量 ECCO 2 R 对呼吸状态的影响,并研究了 NaHCO 3、曲美他莫和生理盐水对二氧化碳吸入模型中低流量 ECCO 2 R 期间呼吸状态的影响:结果:虽然低流量 ECCO 2 R 没有显著改变呼吸频率(ECCO 2 R 前的 92.2% ± 24.3% [平均值 ± 标准差]),但降低了分钟通气量(MV)(ECCO 2 R 前的 78.9% ± 13.5%)。与生理盐水组相比,添加 NaHCO 3 可改善酸血症,但不会改变通气量(分别为 0.451 ± 0.026 升/分钟/千克体重[BW] 与 0.556 ± 0.138 升/分钟/千克体重[BW])。与生理盐水组相比,添加曲美他莫可改善酸血症并降低血压(分别为 0.381 ± 0.050 升/分钟/千克体重 vs 0.556 ± 0.138 升/分钟/千克体重)。NaHCO 3 组在 ECCO 2 R 期间排出的 CO 2 总量低于生理盐水组和曲美他莫组:结论:低流量 ECCO 2 R 降低了受试者在 CO 2 超负荷时保持自主呼吸的 MV。添加 NaHCO 3 可改善酸血症,但不会改变 MV,而添加曲美他莫可改善酸血症并降低 MV。
{"title":"Combined Use of Alkaline Agents With Low-Flow Extracorporeal Carbon Dioxide Removal in Carbon Dioxide Inhalation Models Preserving Inspiratory Efforts.","authors":"Tomonori Yamashita, Akinori Uchiyama, Yusuke Enokidani, Takeshi Yoshida, Yuji Fujino","doi":"10.6705/j.jacme.202403_14(1).0004","DOIUrl":"10.6705/j.jacme.202403_14(1).0004","url":null,"abstract":"<p><strong>Background: </strong>Low-flow extracorporeal CO <sub>2</sub> removal (ECCO <sub>2</sub> R), managed using a renal replacement platform, is useful in achieving lung-protective ventilation with low tidal volume. However, its capacity for CO <sub>2</sub> elimination is limited. Whether this system is valuable in reducing strong inspiratory efforts in respiratory failure is unclear. The combined use of alkaline agents with low-flow ECCO <sub>2</sub> R might be useful in hypercapnic subjects preserving inspiratory efforts.</p><p><strong>Methods: </strong>This study examined the effects of low-flow ECCO <sub>2</sub> R on respiratory status and investigated the effects of NaHCO <sub>3</sub> , trometamol, and saline on respiratory status during low-flow ECCO <sub>2</sub> R in CO <sub>2</sub> inhalation models.</p><p><strong>Results: </strong>Although low-flow ECCO <sub>2</sub> R did not significantly change the respiratory rate (92.2% ± 24.3% [mean ± standard deviation] of that before ECCO <sub>2</sub> R), it reduced minute ventilation (MV) (78.9% ± 13.5% of that before ECCO <sub>2</sub> R). The addition of NaHCO <sub>3</sub> improved acidemia but did not change MV compared with that of the saline group (0.451 ± 0.026 L/min/kg body weight [BW] vs. 0.556 ± 0.138 L/min/kg BW, respectively). The addition of trometamol improved acidemia and reduced MV compared with that of the saline group (0.381 ± 0.050 L/min/kg BW vs. 0.556 ± 0.138 L/min/kg BW, respectively). The total amounts of CO <sub>2</sub> removed during ECCO <sub>2</sub> R in the NaHCO <sub>3</sub> group were lower than those in the saline and trometamol groups.</p><p><strong>Conclusion: </strong>The low-flow ECCO <sub>2</sub> R reduced MV in subjects preserving spontaneous breathing efforts with CO <sub>2</sub> overload. The addition of NaHCO <sub>3</sub> improved acidemia but did not change MV, whereas the addition of trometamol improved acidemia and reduced MV.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"28-38"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Out-of-Hours Admission on Mortality in Patients Who Underwent Thrombectomy Due to Ischemic Stroke. 因缺血性脑卒中接受血栓切除术的患者在非工作时间入院对死亡率的影响。
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2024-03-01 DOI: 10.6705/j.jacme.202403_14(1).0003
Kadir Küçükceran, Mustafa Kürşat Ayrancı, Abdullah Sadık Girişgin, Sedat Koçak, Zerrin Defne Dündar, Osman Koç

Background: It is important to investigate the factors that may delay the diagnosis and treatment process of ischemic stroke. The aim of this study was to investigate whether in-hospital mortality increased in patients who presented to the emergency department out-of-hours and underwent thrombectomy.

Methods: A total of 59 patients who applied to the emergency department between January 1, 2018 and November 1, 2021 and underwent thrombectomy due to ischemic stroke were included in the study. Patient age, gender, thrombectomy success (successful recanalization), in-hospital mortality status, intracranial hemorrhage status after thrombectomy, and out-of-hours admission status were recorded and compared according to out-of-hours admission status.

Results: Twenty-seven (45.8%) patients were male, and the median age was 74 (61-81) years. Forty-two (71.2%) patients applied to the emergency department out-of-hours. In-hospital mortality occurred in 27 (45.8%) patients. There was no statistically significant difference in out-of-hours admission status between the non-survivor group and the survivor group (non-survivor: 24 [75%]; survivor: 18 [66.7%], p = 0.481). Nor was a statistically significant difference found in the intracranial hemorrhage complication rate of the patients admitted out-of-hours compared to the patients admitted during working hours (out-of-hours: 17 [40.5%]; during working hours: 6 [35.3%], p = 0.712).

Conclusion: No statistically significant difference was found in the rate of in-hospital mortality and intracranial bleeding complications in patients who underwent thrombectomy out of working hours compared to during working hours.

背景:研究可能延误缺血性脑卒中诊断和治疗进程的因素非常重要。本研究旨在调查在非工作时间到急诊科就诊并接受血栓切除术的患者的院内死亡率是否升高:研究共纳入了 2018 年 1 月 1 日至 2021 年 11 月 1 日期间因缺血性脑卒中到急诊科就诊并接受血栓切除术的 59 名患者。记录了患者的年龄、性别、血栓切除术成功率(成功再通)、院内死亡率情况、血栓切除术后颅内出血情况以及非工作时间入院情况,并根据非工作时间入院情况进行比较:27例(45.8%)患者为男性,中位年龄为74(61-81)岁。42名患者(71.2%)在非工作时间向急诊科申请入院。27名(45.8%)患者出现院内死亡。非幸存者组和幸存者组在非工作时间入院情况上没有明显的统计学差异(非幸存者:24 [75%];幸存者:18 [66.7%],P = 0.481)。非工作时间入院患者的颅内出血并发症发生率与工作时间入院患者的颅内出血并发症发生率相比,也没有发现明显的统计学差异(非工作时间:17 [40.5%];工作时间:6 [35.3%],P = 0.712):结论:与工作时间相比,在非工作时间接受血栓切除术的患者的院内死亡率和颅内出血并发症发生率没有明显统计学差异。
{"title":"The Effect of Out-of-Hours Admission on Mortality in Patients Who Underwent Thrombectomy Due to Ischemic Stroke.","authors":"Kadir Küçükceran, Mustafa Kürşat Ayrancı, Abdullah Sadık Girişgin, Sedat Koçak, Zerrin Defne Dündar, Osman Koç","doi":"10.6705/j.jacme.202403_14(1).0003","DOIUrl":"10.6705/j.jacme.202403_14(1).0003","url":null,"abstract":"<p><strong>Background: </strong>It is important to investigate the factors that may delay the diagnosis and treatment process of ischemic stroke. The aim of this study was to investigate whether in-hospital mortality increased in patients who presented to the emergency department out-of-hours and underwent thrombectomy.</p><p><strong>Methods: </strong>A total of 59 patients who applied to the emergency department between January 1, 2018 and November 1, 2021 and underwent thrombectomy due to ischemic stroke were included in the study. Patient age, gender, thrombectomy success (successful recanalization), in-hospital mortality status, intracranial hemorrhage status after thrombectomy, and out-of-hours admission status were recorded and compared according to out-of-hours admission status.</p><p><strong>Results: </strong>Twenty-seven (45.8%) patients were male, and the median age was 74 (61-81) years. Forty-two (71.2%) patients applied to the emergency department out-of-hours. In-hospital mortality occurred in 27 (45.8%) patients. There was no statistically significant difference in out-of-hours admission status between the non-survivor group and the survivor group (non-survivor: 24 [75%]; survivor: 18 [66.7%], <i>p</i> = 0.481). Nor was a statistically significant difference found in the intracranial hemorrhage complication rate of the patients admitted out-of-hours compared to the patients admitted during working hours (out-of-hours: 17 [40.5%]; during working hours: 6 [35.3%], <i>p</i> = 0.712).</p><p><strong>Conclusion: </strong>No statistically significant difference was found in the rate of in-hospital mortality and intracranial bleeding complications in patients who underwent thrombectomy out of working hours compared to during working hours.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"20-27"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should I Supplement Vitamin D in a Patient With Sepsis? 我应该为败血症患者补充维生素 D 吗?
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2024-03-01 DOI: 10.6705/j.jacme.202403_14(1).0001
Vedran Kovacic

Sepsis is a potentially fatal organ failure produced by the host's immune response to infection. It is critical to identify risk factors associated with a poor prognosis in septic patients in order to develop new therapy options. Vitamin D deficiency (25-hydroxyvitamin cholecalciferol < 20 ng/mL) is common in critical and septic patients. Serum vitamin D concentrations are associated with an increased incidence of mortality in critically ill adult patients. In critically ill patients, vitamin D supplementation (a very high vitamin D 3 or cholecalciferol loading dosage as a single bolus dose ranging from 400,000 to 540,000 IU) is feasible and safe. Some of the trials and their post-hoc analyses evaluating vitamin D supplementation in severely sick individuals, including septic patients, suggested possible benefits in mortality (reduced 28-day mortality in the range of 8.1%-17.5%), and other outcomes (reduction in hospital length in the range from 9 to 18 days, and decrease in duration of mechanical ventilation in the range from 5 to 10 days). Despite the fact that many studies support the provision of vitamin D to septic patients, there are still many studies that contradict this opinion, and there is still debate about the recommendation to use vitamin D in sepsis. A pragmatic clinical approach in severe sepsis could be supplementation of vitamin D if serum levels are diminished (< 30 ng/mL). It appears that a single ultrahigh dose of vitamin D 3 (cholecalciferol) could be administered to the septic patient via an enteral tube, followed by daily or monthly maintenance doses. Parenteral administration might be reserved for a subgroup of septic patients with gastrointestinal, hepatic, or renal dysfunction. Future clinical trials designed exclusively for septic patients are required to assess the potential advantages of vitamin D. Possible impacts of selective activators of vitamin D receptors, such as paricalcitol, should be elucidated in sepsis. This emphasizes the requirement for more study and confirmation of any potential beneficial effects of vitamin D in sepsis.

败血症是宿主对感染的免疫反应导致的潜在致命性器官衰竭。确定与败血症患者预后不良相关的风险因素以开发新的治疗方案至关重要。维生素 D 缺乏(25-羟维生素胆钙化醇 < 20 ng/mL)在危重病人和脓毒症患者中很常见。血清维生素 D 浓度与成年重症患者死亡率的增加有关。在危重病人中,补充维生素 D(维生素 D 3 或胆钙化醇的负荷剂量非常高,单次栓剂剂量从 400,000 到 540,000 IU 不等)是可行且安全的。一些对重症患者(包括败血症患者)补充维生素 D 进行评估的试验及其事后分析表明,补充维生素 D 可降低死亡率(28 天死亡率降低了 8.1%-17.5%)和其他结果(住院时间缩短了 9 到 18 天,机械通气时间缩短了 5 到 10 天)。尽管许多研究都支持为脓毒症患者提供维生素 D,但仍有许多研究与这一观点相悖,关于在脓毒症患者中使用维生素 D 的建议仍存在争议。在严重脓毒症中,如果血清中的维生素 D 水平降低(< 30 ng/mL),可以采取一种务实的临床方法来补充维生素 D。脓毒症患者似乎可以通过肠管服用一次超大剂量的维生素 D 3(胆钙化醇),然后每天或每月服用一次。肠外给药可保留给胃肠道、肝脏或肾脏功能障碍的败血症患者。未来需要进行专门针对脓毒症患者的临床试验,以评估维生素 D 的潜在优势。应阐明维生素 D 受体选择性激活剂(如帕立骨化醇)对脓毒症可能产生的影响。这强调了对维生素 D 在脓毒症中的潜在有益作用进行更多研究和确认的必要性。
{"title":"Should I Supplement Vitamin D in a Patient With Sepsis?","authors":"Vedran Kovacic","doi":"10.6705/j.jacme.202403_14(1).0001","DOIUrl":"10.6705/j.jacme.202403_14(1).0001","url":null,"abstract":"<p><p>Sepsis is a potentially fatal organ failure produced by the host's immune response to infection. It is critical to identify risk factors associated with a poor prognosis in septic patients in order to develop new therapy options. Vitamin D deficiency (25-hydroxyvitamin cholecalciferol < 20 ng/mL) is common in critical and septic patients. Serum vitamin D concentrations are associated with an increased incidence of mortality in critically ill adult patients. In critically ill patients, vitamin D supplementation (a very high vitamin D <sub>3</sub> or cholecalciferol loading dosage as a single bolus dose ranging from 400,000 to 540,000 IU) is feasible and safe. Some of the trials and their post-hoc analyses evaluating vitamin D supplementation in severely sick individuals, including septic patients, suggested possible benefits in mortality (reduced 28-day mortality in the range of 8.1%-17.5%), and other outcomes (reduction in hospital length in the range from 9 to 18 days, and decrease in duration of mechanical ventilation in the range from 5 to 10 days). Despite the fact that many studies support the provision of vitamin D to septic patients, there are still many studies that contradict this opinion, and there is still debate about the recommendation to use vitamin D in sepsis. A pragmatic clinical approach in severe sepsis could be supplementation of vitamin D if serum levels are diminished (< 30 ng/mL). It appears that a single ultrahigh dose of vitamin D <sub>3</sub> (cholecalciferol) could be administered to the septic patient via an enteral tube, followed by daily or monthly maintenance doses. Parenteral administration might be reserved for a subgroup of septic patients with gastrointestinal, hepatic, or renal dysfunction. Future clinical trials designed exclusively for septic patients are required to assess the potential advantages of vitamin D. Possible impacts of selective activators of vitamin D receptors, such as paricalcitol, should be elucidated in sepsis. This emphasizes the requirement for more study and confirmation of any potential beneficial effects of vitamin D in sepsis.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"1-8"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10933588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in Artificial Intelligence in Emergency Medicine in Taiwan: A Narrative Review. 台湾急诊医学人工智能的发展:叙述性综述。
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2024-03-01 DOI: 10.6705/j.jacme.202403_14(1).0002
Bing-Hung Shih, Chien-Chun Yeh

The rapid progression of artificial intelligence (AI) in healthcare has greatly influenced emergency medicine, particularly in Taiwan-a nation celebrated for its technological innovation and advanced public healthcare. This narrative review examines the current status of AI applications in Taiwan's emergency medicine and highlights notable achievements and potential areas for growth. AI has wide capabilities encompass a broad range, including disease prediction, diagnostic imaging interpretation, and workflow enhancement. While the integration of AI presents promising advancements, it is not devoid of challenges. Concerns about the interpretability of AI models, the importance of dataset accuracy, the necessity for external validation, and ethical quandaries emphasize the need for a balanced approach. Regulatory oversight also plays a crucial role in ensuring the safe and effective deployment of AI tools in clinical settings. As its footprint continues to expand in medical education and other areas, addressing these challenges is imperative to harness the full potential of AI for transforming emergency medicine in Taiwan.

人工智能(AI)在医疗保健领域的快速发展极大地影响了急诊医学,尤其是在台湾--一个以技术创新和先进的公共医疗保健而闻名的国家。这篇叙述性综述探讨了人工智能在台湾急诊医学中的应用现状,并重点介绍了显著的成就和潜在的发展领域。人工智能的功能十分广泛,包括疾病预测、影像诊断解读和工作流程改进。虽然人工智能的整合带来了充满希望的进步,但也并非没有挑战。人们对人工智能模型的可解释性、数据集准确性的重要性、外部验证的必要性以及道德问题的关注,都强调了采取平衡方法的必要性。监管部门的监督对于确保在临床环境中安全有效地部署人工智能工具也起着至关重要的作用。随着人工智能在医学教育和其他领域的应用不断扩大,要充分发挥人工智能的潜力,改变台湾的急诊医学,解决这些挑战势在必行。
{"title":"Advancements in Artificial Intelligence in Emergency Medicine in Taiwan: A Narrative Review.","authors":"Bing-Hung Shih, Chien-Chun Yeh","doi":"10.6705/j.jacme.202403_14(1).0002","DOIUrl":"10.6705/j.jacme.202403_14(1).0002","url":null,"abstract":"<p><p>The rapid progression of artificial intelligence (AI) in healthcare has greatly influenced emergency medicine, particularly in Taiwan-a nation celebrated for its technological innovation and advanced public healthcare. This narrative review examines the current status of AI applications in Taiwan's emergency medicine and highlights notable achievements and potential areas for growth. AI has wide capabilities encompass a broad range, including disease prediction, diagnostic imaging interpretation, and workflow enhancement. While the integration of AI presents promising advancements, it is not devoid of challenges. Concerns about the interpretability of AI models, the importance of dataset accuracy, the necessity for external validation, and ethical quandaries emphasize the need for a balanced approach. Regulatory oversight also plays a crucial role in ensuring the safe and effective deployment of AI tools in clinical settings. As its footprint continues to expand in medical education and other areas, addressing these challenges is imperative to harness the full potential of AI for transforming emergency medicine in Taiwan.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"14 1","pages":"9-19"},"PeriodicalIF":0.6,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10938302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140131528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperbaric Oxygen Therapy in Hydrogen Sulfide Poisoning: A Case Report. 硫化氢中毒的高压氧疗法:病例报告。
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2023-12-01 DOI: 10.6705/j.jacme.202312_13(4).0004
Kun-Yu Yang, Chen-Ching Chen

For several decades, hydrogen sulfide (H2S) has been a toxic gas affecting people, particularly in workplaces. However, no effective therapy is available to counteract H2S poisoning. Herein, we report the case of a 34-year-old male field worker who experienced H2S poisoning due to an accident at work. He presented to the emergency room with dyspnea, drowsiness, and dizziness. Computed tomography revealed a normal brain mass. An initial electrocardiogram revealed sinus tachycardia. Therefore, 10 mL nitrite was administered intravenously. However, the symptoms were not relieved as expected. Hyperbaric oxygen was promptly administered. Symptoms were relieved rapidly after three sessions of hyperbaric oxygen therapy. Subsequently, the patient completely recovered. During severe H2S intoxication, early administration of hyperbaric oxygen therapy can prevent the disruption of aerobic cellular respiration and save lives.

几十年来,硫化氢(H2S)一直是影响人类的有毒气体,尤其是在工作场所。然而,目前还没有有效的疗法来应对 H2S 中毒。在此,我们报告了一名 34 岁男性野外工作者因工作事故导致 H2S 中毒的病例。他因呼吸困难、嗜睡和头晕前往急诊室就诊。计算机断层扫描显示脑部肿块正常。初步心电图显示为窦性心动过速。因此,医生静脉注射了 10 毫升亚硝酸盐。然而,症状并未如期缓解。医生立即为其注射了高压氧。高压氧治疗三个疗程后,症状迅速缓解。随后,患者完全康复。在严重的 H2S 中毒中,及早进行高压氧治疗可以防止有氧细胞呼吸受到破坏,从而挽救生命。
{"title":"Hyperbaric Oxygen Therapy in Hydrogen Sulfide Poisoning: A Case Report.","authors":"Kun-Yu Yang, Chen-Ching Chen","doi":"10.6705/j.jacme.202312_13(4).0004","DOIUrl":"https://doi.org/10.6705/j.jacme.202312_13(4).0004","url":null,"abstract":"<p><p>For several decades, hydrogen sulfide (H<sub>2</sub>S) has been a toxic gas affecting people, particularly in workplaces. However, no effective therapy is available to counteract H<sub>2</sub>S poisoning. Herein, we report the case of a 34-year-old male field worker who experienced H<sub>2</sub>S poisoning due to an accident at work. He presented to the emergency room with dyspnea, drowsiness, and dizziness. Computed tomography revealed a normal brain mass. An initial electrocardiogram revealed sinus tachycardia. Therefore, 10 mL nitrite was administered intravenously. However, the symptoms were not relieved as expected. Hyperbaric oxygen was promptly administered. Symptoms were relieved rapidly after three sessions of hyperbaric oxygen therapy. Subsequently, the patient completely recovered. During severe H<sub>2</sub>S intoxication, early administration of hyperbaric oxygen therapy can prevent the disruption of aerobic cellular respiration and save lives.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"13 4","pages":"159-161"},"PeriodicalIF":0.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138804993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Ventilator Mechanics and Mortality Between COVID-19 Versus Non-COVID-19 Acute Respiratory Distress Syndrome Patients: A Cross-Sectional Study. COVID-19 与非 COVID-19 急性呼吸窘迫综合征患者呼吸机力学和死亡率的比较:一项横断面研究。
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2023-12-01 DOI: 10.6705/j.jacme.202312_13(4).0002
Sadaf Hanif, Madiha Iqbal, Sher Muhammad Sethi, Amber Sabeen

Background: We aim to assess the differences in ventilator mechanics and mortality of acute respiratory distress syndrome (ARDS) between patients with and without COVID-19. It might serve as a milestone in reshaping management protocols by providing very preliminary evidence in this direction.

Methods: It was a cross-sectional study that included adult patients aged 18 years or above admitted to the medical intensive care unit of our tertiary care hospital from January to December 2021 with the diagnosis of ARDS. Patients were divided into two groups. Group I were patients who had ARDS with COVID-19 infection while group II were those who had ARDS without COVID-19 infection. Both groups were compared in terms of clinical and respiratory mechanics of mechanical ventilators and mortality.

Results: The study included 135 patients, 68 of whom were in group I, and 67 were in group II. In the COVID-19 group, the median age was 60; while in the non-COVID-19 group, it was 64. There were 50% male patients in both groups. ARDS was more severe in COVID-19 (n = 44, 58%) than in the non-COVID group (n = 31, 41.3%, p-value = 0.030). The median PaO2/FiO2 ratio was 122.5 (interquartile range [IQR]: 93-160) in COVID-19 and was 180 (IQR: 127-248) in the non-COVID-19 group. Patient proning was higher (63% vs. 37%) in the COVID-19 group. In the COVID-19 group, 44 patients died compared to 32 in the non-COVID group (p-value = 0.060).

Conclusions: COVID-19 patients had severe ARDS compared with non-COVID patients. Despite this, ventilator mechanics and mortality were not significantly different between both groups. It appears that more proning strategies were observed in the COVID-19 group and may have some positive effects.

背景:我们旨在评估有COVID-19和没有COVID-19的急性呼吸窘迫综合征(ARDS)患者在呼吸机力学和死亡率方面的差异。通过提供这方面的初步证据,该研究可能成为重塑管理方案的里程碑:这是一项横断面研究,研究对象为 2021 年 1 月至 12 月期间入住本院三级医院内科重症监护室、诊断为 ARDS 的 18 岁或以上成年患者。患者被分为两组。第一组为感染 COVID-19 的 ARDS 患者,第二组为未感染 COVID-19 的 ARDS 患者。两组患者在机械呼吸机的临床和呼吸力学以及死亡率方面进行了比较:研究共纳入 135 名患者,其中 68 人属于 I 组,67 人属于 II 组。COVID-19 组患者的中位年龄为 60 岁,而非 COVID-19 组患者的中位年龄为 64 岁。两组中男性患者均占 50%。COVID-19 组(44 人,58%)的 ARDS 比非 COVID 组(31 人,41.3%,P 值 = 0.030)更严重。COVID-19 组的 PaO2/FiO2 比值中位数为 122.5(四分位数间距 [IQR]:93-160),非 COVID-19 组为 180(IQR:127-248)。COVID-19 组患者的俯卧位更高(63% 对 37%)。COVID-19组有44名患者死亡,而非COVID-19组有32名患者死亡(P值=0.060):结论:与非 COVID 患者相比,COVID-19 患者的 ARDS 严重。结论:与非 COVID 患者相比,COVID-19 患者的 ARDS 严重,尽管如此,两组患者的呼吸机力学和死亡率并无显著差异。在 COVID-19 组中似乎观察到了更多的俯卧撑策略,这可能会产生一些积极的影响。
{"title":"Comparison of Ventilator Mechanics and Mortality Between COVID-19 Versus Non-COVID-19 Acute Respiratory Distress Syndrome Patients: A Cross-Sectional Study.","authors":"Sadaf Hanif, Madiha Iqbal, Sher Muhammad Sethi, Amber Sabeen","doi":"10.6705/j.jacme.202312_13(4).0002","DOIUrl":"https://doi.org/10.6705/j.jacme.202312_13(4).0002","url":null,"abstract":"<p><strong>Background: </strong>We aim to assess the differences in ventilator mechanics and mortality of acute respiratory distress syndrome (ARDS) between patients with and without COVID-19. It might serve as a milestone in reshaping management protocols by providing very preliminary evidence in this direction.</p><p><strong>Methods: </strong>It was a cross-sectional study that included adult patients aged 18 years or above admitted to the medical intensive care unit of our tertiary care hospital from January to December 2021 with the diagnosis of ARDS. Patients were divided into two groups. Group I were patients who had ARDS with COVID-19 infection while group II were those who had ARDS without COVID-19 infection. Both groups were compared in terms of clinical and respiratory mechanics of mechanical ventilators and mortality.</p><p><strong>Results: </strong>The study included 135 patients, 68 of whom were in group I, and 67 were in group II. In the COVID-19 group, the median age was 60; while in the non-COVID-19 group, it was 64. There were 50% male patients in both groups. ARDS was more severe in COVID-19 (n = 44, 58%) than in the non-COVID group (n = 31, 41.3%, <i>p</i>-value = 0.030). The median PaO<sub>2</sub>/FiO<sub>2</sub> ratio was 122.5 (interquartile range [IQR]: 93-160) in COVID-19 and was 180 (IQR: 127-248) in the non-COVID-19 group. Patient proning was higher (63% vs. 37%) in the COVID-19 group. In the COVID-19 group, 44 patients died compared to 32 in the non-COVID group (<i>p</i>-value = 0.060).</p><p><strong>Conclusions: </strong>COVID-19 patients had severe ARDS compared with non-COVID patients. Despite this, ventilator mechanics and mortality were not significantly different between both groups. It appears that more proning strategies were observed in the COVID-19 group and may have some positive effects.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"13 4","pages":"144-149"},"PeriodicalIF":0.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138804992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous Balloon Catheter Occlusion to Treat Extravasation from an Inferior Vena Cava Laceration Associated With a Pelvic Fracture Following Blunt Abdominal Trauma: A Case Report. 经皮球囊导管闭塞术治疗腹部钝挫伤后骨盆骨折引起的下腔静脉裂伤外渗:病例报告。
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2023-12-01 DOI: 10.6705/j.jacme.202312_13(4).0005
Cheng-Yi Tsai, Chia-Hsiu Chang, Yao Chung-Tay

Blunt abdominal injury with pelvic fracture is common in polytrauma cases and is a major challenge for emergency physicians. Fluid resuscitation and massive transfusion protocol should be activated when pelvic fracture patients are found in hypovolemic shock. At the emergency department, resuscitative endovascular balloon occlusion of the aorta may be performed to temporarily control bleeding. Finally, a damage control operation or trans-arterial embolization may be performed in the hybrid operating room.

腹部钝伤伴骨盆骨折在多发性创伤病例中很常见,是急诊医生面临的一大挑战。当发现骨盆骨折患者出现低血容量性休克时,应启动液体复苏和大量输血方案。在急诊科,可对主动脉进行血管内球囊闭塞抢救,以暂时控制出血。最后,可在混合手术室进行损伤控制手术或经动脉栓塞术。
{"title":"Percutaneous Balloon Catheter Occlusion to Treat Extravasation from an Inferior Vena Cava Laceration Associated With a Pelvic Fracture Following Blunt Abdominal Trauma: A Case Report.","authors":"Cheng-Yi Tsai, Chia-Hsiu Chang, Yao Chung-Tay","doi":"10.6705/j.jacme.202312_13(4).0005","DOIUrl":"https://doi.org/10.6705/j.jacme.202312_13(4).0005","url":null,"abstract":"<p><p>Blunt abdominal injury with pelvic fracture is common in polytrauma cases and is a major challenge for emergency physicians. Fluid resuscitation and massive transfusion protocol should be activated when pelvic fracture patients are found in hypovolemic shock. At the emergency department, resuscitative endovascular balloon occlusion of the aorta may be performed to temporarily control bleeding. Finally, a damage control operation or trans-arterial embolization may be performed in the hybrid operating room.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"13 4","pages":"162-165"},"PeriodicalIF":0.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138804994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Young Woman With Transient Blindness After Mild COVID-19. 一名轻度 COVID-19 后短暂失明的年轻女性。
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2023-12-01 DOI: 10.6705/j.jacme.202312_13(4).0007
Francisco Caiza-Zambrano, Paula DAmico, Fabio Maximiliano Gonzalez, Julio César Galarza, Ariel Bustos, Ricardo Reisin, Pablo Bonardo
{"title":"A Young Woman With Transient Blindness After Mild COVID-19.","authors":"Francisco Caiza-Zambrano, Paula DAmico, Fabio Maximiliano Gonzalez, Julio César Galarza, Ariel Bustos, Ricardo Reisin, Pablo Bonardo","doi":"10.6705/j.jacme.202312_13(4).0007","DOIUrl":"https://doi.org/10.6705/j.jacme.202312_13(4).0007","url":null,"abstract":"","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"13 4","pages":"169-170"},"PeriodicalIF":0.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138804991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Gastro-Caval Fistula Due to Penetrating Trauma: A Vital Emergency. 穿透性创伤导致胃腔瘘的罕见病例:生命攸关的紧急情况
IF 0.6 Q4 EMERGENCY MEDICINE Pub Date : 2023-12-01 DOI: 10.6705/j.jacme.202312_13(4).0006
Şahap Törenek, Ezel Yaltırık Bilgin, Pınar Özdemir Akdur

In the literature no case of gastro-caval fistula due to penetrating trauma has been reported. We aimed to present a case of gastro-caval fistula presenting with massive hematemesis after a penetrating injury. A 20-year-old male patient applied to the emergency department with a complaint of projectile hematemesis after a knife penetrated the epigastric region. Contrast-enhanced abdominal computerized tomography (CT) showed a large hematoma around the inferior vena cava (IVC) and a fistula tract extending between the IVC and the gastric antrum. The patient underwent vena cava ligation and primary gastric repair. The patient, who was hypotensive and intubated in the post-operative intensive care unit, died on the second day after the operation. Because of the risk of sudden hypotension and shock from massive bleeding, gastro-caval fistula should be kept in mind in penetrating trauma; a rapid diagnosis should be made using a contrast-enhanced CT scan.

文献中还没有关于穿透性创伤导致胃腔瘘的病例报道。我们旨在介绍一例穿透性损伤后出现大量吐血的胃腔瘘病例。一名20岁的男性患者因被刀刺入上腹部后出现喷射性吐血而到急诊科就诊。对比增强腹部计算机断层扫描(CT)显示,下腔静脉(IVC)周围有巨大血肿,IVC和胃窦之间有瘘道延伸。患者接受了腔静脉结扎术和原发性胃修补术。患者术后出现低血压并在重症监护室插管,于术后第二天死亡。由于大量出血有可能导致突发低血压和休克,因此在穿透性创伤中应注意胃腔瘘;应使用对比增强 CT 扫描进行快速诊断。
{"title":"A Rare Case of Gastro-Caval Fistula Due to Penetrating Trauma: A Vital Emergency.","authors":"Şahap Törenek, Ezel Yaltırık Bilgin, Pınar Özdemir Akdur","doi":"10.6705/j.jacme.202312_13(4).0006","DOIUrl":"https://doi.org/10.6705/j.jacme.202312_13(4).0006","url":null,"abstract":"<p><p>In the literature no case of gastro-caval fistula due to penetrating trauma has been reported. We aimed to present a case of gastro-caval fistula presenting with massive hematemesis after a penetrating injury. A 20-year-old male patient applied to the emergency department with a complaint of projectile hematemesis after a knife penetrated the epigastric region. Contrast-enhanced abdominal computerized tomography (CT) showed a large hematoma around the inferior vena cava (IVC) and a fistula tract extending between the IVC and the gastric antrum. The patient underwent vena cava ligation and primary gastric repair. The patient, who was hypotensive and intubated in the post-operative intensive care unit, died on the second day after the operation. Because of the risk of sudden hypotension and shock from massive bleeding, gastro-caval fistula should be kept in mind in penetrating trauma; a rapid diagnosis should be made using a contrast-enhanced CT scan.</p>","PeriodicalId":14846,"journal":{"name":"Journal of acute medicine","volume":"13 4","pages":"166-168"},"PeriodicalIF":0.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10711364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138804990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of acute medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1